vai alle Pubblicazioni
Publications prior to 2004
Lavori in extenso - antecedenti il 2004
8. Oncogene.
2003, 22(58):9217-24.
Kumar R., Angelini S., Hemminki K. “Activating BRAF
and N-Ras mutations in sporadic primary melanomas: an invers
association with allelic loss on chromosome 9”.
7. G Ital Med Lav Ergon. 2003, 25(3):342-3.
Hrelia P., Maffei F., Angelini S., Cantelli-Forti G.
“Biomarkers of effects and susceptibility for risk
assessment”.
6. Clin Cancer Res. 2003, 9(9):3362-8.
Kumar R., Angelini S., Czene K., Sauroja I.,
Hahka-Kemppinen M., Pyrhonen S., Hemminki K. “BRAF mutations in
metastatic melanoma: a possible association with clinical
outcome”.
5. Mutagenesis. 2003, 18(2):207-9.
Kumar R., Angelini S., Hemminki K. “Simultaneous
detection of the exon 10 polymorphism and a novel intronic single
base insertion polymorphism in the XPD gene using single strand
conformation polymorphism”.
4. Environ Mol Mutagen. 2003, 41(1):37-42.
Hou S.M., Ryk C., Kannio A., Angelini S., Falt S., Nyberg
F., Husgafvel-Pursiainen K. “Influence of common XPD and XRCC1
variant alleles on p53 mutations in lung Tumors”.
3. Mutagenesis. 2002, 17(5):405-9.
Maffei F., Angelini S., Forti G.C., Lodi V., Violante
F.S., Mattioli S., Hrelia P. “Micronuclei frequencies in
hospital workers occupationally exposed to low levels of ionizing
radiation: influence of smoking status and other factors”.
2. Carcinogenesis. 2002, 23(4):599-603.
Hou S.M., Falt S., Angelini S., Yang K., Nyberg F.,
Lambert B., Hemminki K. “The XPD variant alleles are associated
with increased aromatic DNA adduct level and lung cancer
risk”.
1. Carcinogenesis. 2001, 22(8):1185-8.
Hemminki K., Xu G., Angelini S., Snellman E., Jansen
C.T., Lambert B., Hou S.M. “XPD exon 10 and 23 polymorphisms and
DNA repair in human skin in situ”.
